Overall rank by patents
#809
Across all tracked assignees
USPTO PatentsView assignee record - 570 granted patents across 75 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
The holds 570 US patents across 75 technology areas, rank #809 of 50,000 tracked assignees.
The Cleveland Clinic Foundation has been granted 570 US utility patents between 2015 and 2025, placing The Cleveland Clinic Foundation at rank #809 across all assignees tracked by PlainPatent. This portfolio spans 75 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, The Cleveland Clinic Foundation is one of the broader-portfolio assignees in the PatentsView dataset. By volume, The sits between Gyrus ACMI, Inc. (572 patents, rank #805) and Sekisui Chemical Co., Ltd. (565 patents, rank #813) - the closest US assignees by grant volume. The composite Innovation Score of 61.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 245 grants, compared with 325 in the 2015–2019 window, a -25% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. The Cleveland Clinic Foundation's 15.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 75 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark The Cleveland Clinic Foundation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Gyrus ACMI, Inc.
572 patents
Honor Device Co., Ltd.
571 patents
MTU Aero Engines AG
571 patents
Getac Technology Corporation
570 patents
Wonderland Switzerland AG
570 patents
The Cleveland Clinic Foundation
570 patents
Hill-Rom Services, Inc.
569 patents
Tetra Laval Holdings & Finance S.A.
568 patents
SEKISUI CHEMICAL CO., LTD.
565 patents
What this shows The holds 570 patents at rank #809, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #809 in granted patent volume.
Other assignees with the most granted patents in The's primary technology class.
The's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
61 Top 3% higher than 97% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 77 | 13.5% |
| 2016 | 57 | 10.0% |
| 2017 | 73 | 12.8% |
| 2018 | 58 | 10.2% |
| 2019 | 60 | 10.5% |
| 2020 | 54 | 9.5% |
| 2021 | 48 | 8.4% |
| 2022 | 43 | 7.5% |
| 2023 | 40 | 7.0% |
| 2024 | 35 | 6.1% |
| 2025 | 25 | 4.4% |
Top 15 of 75 technology areas
Overall rank by patents
#809
Across all tracked assignees
61.3 out of 100
How to use this portfolio
The's 570 grants land it in the top 3% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.